Rothschild & CO Asset Management Us Inc. Care Dx, Inc. Transaction History
Rothschild & CO Asset Management Us Inc.
- $6.56 Billion
- Q4 2022
A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Care Dx, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 266,132 shares of CDNA stock, worth $5.48 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
266,132
Previous 284,227
6.37%
Holding current value
$5.48 Million
Previous $4.84 Million
37.25%
% of portfolio
0.05%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$109 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$93.5 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$64.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$61.6 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$42 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.1B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...